AntiCancer (United States)

967 papers and 32.8k indexed citations i.

About

In recent decades, authors affiliated with AntiCancer (United States) have published 967 papers, which have received a total of 32.8k indexed citations. Scholars at this organization have produced 675 papers in Biotechnology, 373 papers in Biomedical Engineering and 310 papers in Genetics on the topics of Cancer Research and Treatments (671 papers), Nanoplatforms for cancer theranostics (346 papers) and Virus-based gene therapy research (293 papers). Their work is cited by papers focused on Biotechnology (14.2k citations), Molecular Biology (11.1k citations) and Biomedical Engineering (10.6k citations). Authors at AntiCancer (United States) collaborate with scholars in United States, Japan and China and have published in prestigious journals including Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry. Some of AntiCancer (United States)'s most productive authors include Robert M. Hoffman, Michael Bouvet, Meng Yang, Lingna Li, Ming Zhao, Eugene Baranov, Ping Jiang, Yasuyuki Amoh, Sheldon Penman and Richard M. Hoffman.

In The Last Decade

Fields of papers published by authors at AntiCancer (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with AntiCancer (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with AntiCancer (United States) at the time of their publication.

Countries citing scholars working at AntiCancer (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at AntiCancer (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AntiCancer (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AntiCancer (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Brockhouse Institute for Materials Research Breakdown of academic impact, for scholars at Office National de la Chasse et de la Faune Sauvage Breakdown of academic impact, for scholars at Chapel Allerton Hospital Breakdown of academic impact, for scholars at Cancer Clinic Breakdown of academic impact, for scholars at RELX Group (Netherlands) Breakdown of academic impact, for scholars at Beijing Graphene Institute Breakdown of academic impact, for scholars at Centers for Disease Control and Prevention Breakdown of academic impact, for scholars at Sidney & Lois Eskenazi Hospital
Rankless by CCL
2025